Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DAY M. D., RAND M. J. A hypothesis for the mode of action of alpha-methyldopa in relieving hypertension. J Pharm Pharmacol. 1963 Apr;15:221–224. doi: 10.1111/j.2042-7158.1963.tb12778.x. [DOI] [PubMed] [Google Scholar]
- Jerums G., Ebringer A., Doyle A. E. A comparison of guanacline with methyldopa in the treatment of hypertension. Med J Aust. 1968 Sep 14;2(11):466–468. doi: 10.5694/j.1326-5377.1968.tb82941.x. [DOI] [PubMed] [Google Scholar]
- Louis W. J., Doyle A. E., Jerums G., Kincaid-Smith P. Methyldopa and haemolytic anaemia. Med J Aust. 1967 Jul 15;2(3):104–106. doi: 10.5694/j.1326-5377.1966.tb72744.x. [DOI] [PubMed] [Google Scholar]
- Mathew T. H., Kincaid-Smith P., Doyle A. E., Baird C. W. A comparison of the hyperuricaemic effect of chlorothiazide and quinethazone. Med J Aust. 1967 Mar 11;1(10):493–495. doi: 10.5694/j.1326-5377.1967.tb21409.x. [DOI] [PubMed] [Google Scholar]
- Rand M. J., Wilson J. Mechanisms of the pressor and depressor actions of St 155 (2-(2,6--dichlorophenylamino)-2-imidazoline hydrochloride, Catapres). Eur J Pharmacol. 1968 Apr;3(1):27–33. doi: 10.1016/0014-2999(68)90044-7. [DOI] [PubMed] [Google Scholar]